Universal Health Services, Inc. (UHS) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1162266,
    "name": "Universal Health Services, Inc.",
    "stock_name": "Universal Health Services, Inc.",
    "full_name": "Universal Health Services, Inc.",
    "name_url": "stocks-analysis/universal-health-services-inc",
    "exchange": 207,
    "exchangecode": "NYS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "230.59",
    "chg": 0.44,
    "chgp": "0.19%",
    "dir": 1,
    "prev_price": "230.15",
    "mcapval": "11,819.20",
    "mcap": "Small Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Hospital",
    "ind_code": 3360,
    "indexname": "S&P 500",
    "isin": "US9139031002",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "253.81 k",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/universal-health-services-inc-1162266-207&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Universal Health Services, Inc. Hits New 52-Week High of $214.10",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/universal-health-services-inc-hits-new-52-week-high-of-21410-3649210",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/UniversalHealth_priceRelatedfactors_3649210.png",
        "date": "2025-10-27 16:42:49",
        "description": "Universal Health Services, Inc. achieved a new 52-week high of USD 214.10 on October 24, 2025, reflecting strong performance in the hospital industry. The company has shown an 11.51% increase over the past year and maintains a favorable P/E ratio, robust dividend yield, and solid financial health metrics."
      },
      {
        "title": "Universal Health Services Faces Valuation Shift Amid Mixed Financial Performance",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/universal-health-services-downgraded-from-buy-to-hold-amid-valuation-concerns-3640185",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/UniversalHealth_mojoScore_3640185.png",
        "date": "2025-10-23 15:40:20",
        "description": "Universal Health Services, Inc. has recently experienced a change in its evaluation score, reflecting a shift in its valuation grade. The company's financial metrics show a mixed performance, with strong operational capabilities and consistent positive results, despite underperforming compared to the broader market over the past year."
      },
      {
        "title": "Is Universal Health Services, Inc. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-universal-health-services-inc-overvalued-or-undervalued-3637490",
        "imagepath": "",
        "date": "2025-10-21 12:03:23",
        "description": "As of 17 October 2025, the valuation grade for Universal Health Services, Inc. has moved from attractive to very expensive, indicating a shift towards overvaluation. The company appears to be overvalued based on its P/E ratio of 10, which is significantly lower than the peer average, such as Chemed Corp. with a P/E of 56.91, and its EV to EBITDA ratio of 7.18, which also trails behind peers like Surgery Partners, Inc. at 8.44. Additionally, the PEG ratio stands at a notably low 0.14, suggesting that the stock may not be justified at its current price given its growth prospects.\n\nIn comparison to its peers, Universal Health Services, Inc. has a lower valuation profile, with its EV to EBIT at 9.61 compared to Chemed Corp.'s 37.72 and Premier, Inc.'s 9.86. Despite a strong recent performance with a 3-year return of 116.60% compared to the S&P 500's 81.19%, the company's 1-year return of -12.64% against the S&P..."
      },
      {
        "title": "Universal Health Services, Inc. Experiences Revision in Its Stock Evaluation Amid Competitive Market Dynamics",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/universal-health-services-valuation-grade-downgraded-from-attractive-to-very-expensive-3640990",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/UniversalHealth_valuationdot_3640990.png",
        "date": "2025-10-20 17:05:53",
        "description": "Universal Health Services, Inc. has adjusted its valuation, showcasing a P/E ratio of 10 and a price-to-book value of 1.80. The company features a strong dividend yield of 46.01% and competitive returns on capital and equity, positioning itself favorably against industry peers."
      },
      {
        "title": "Is Universal Health Services, Inc. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-universal-health-services-inc-overvalued-or-undervalued-3634360",
        "imagepath": "",
        "date": "2025-10-20 12:21:01",
        "description": "As of 17 October 2025, the valuation grade for Universal Health Services, Inc. has moved from attractive to very expensive. The company appears to be overvalued based on its current metrics. The P/E ratio stands at 10, while the industry average is not provided, indicating a potential premium valuation. Additionally, the EV to EBITDA ratio is 7.18, and the PEG ratio is notably low at 0.14, suggesting limited growth expectations relative to its price.\n\nIn comparison to its peers, Universal Health Services, Inc. has a lower P/E ratio than Chemed Corp. at 56.91 and National HealthCare Corp. at 18.51, but it is higher than Surgery Partners, Inc. at 31.47. The company's recent stock performance shows a 1-week return of 4.31% and a year-to-date return of 14.01%, both outperforming the S&P 500's returns of 1.70% and 13.30%, respectively. However, the 1-year return of -12.64% significantly lags behind the S&P 500's..."
      },
      {
        "title": "Is Universal Health Services, Inc. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-universal-health-services-inc-overvalued-or-undervalued-3631896",
        "imagepath": "",
        "date": "2025-10-19 11:58:32",
        "description": "As of 17 October 2025, the valuation grade for Universal Health Services, Inc. has moved from attractive to very expensive, indicating a shift towards overvaluation. The company is currently considered overvalued based on its P/E ratio of 10, a Price to Book Value of 1.80, and an EV to EBITDA of 7.18. In comparison, peers such as Chemed Corp. have a significantly higher P/E ratio of 56.91, while National HealthCare Corp. shows a fair valuation with a P/E of 18.51.\n\nDespite strong recent performance, with a 1-week return of 4.31% compared to the S&P 500's 1.70%, the longer-term outlook reveals a concerning 1-year return of -12.64% against the S&P 500's 14.08%. This suggests that while the stock may have short-term momentum, its overall valuation appears stretched relative to its peers and historical performance...."
      },
      {
        "title": "Universal Health Services, Inc. Experiences Valuation Adjustment Amidst Market Dynamics and Financial Metrics",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/universal-health-services-changes-valuation-grade-from-expensive-to-very-expensive-3617477",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/UniversalHealth_valuationdot_3617477.png",
        "date": "2025-10-13 15:54:54",
        "description": "Universal Health Services, Inc. has adjusted its valuation, reflecting changes in financial metrics and market position. The company reports a P/E ratio of 10, a price-to-book value of 1.80, and a strong dividend yield of 46.01%. Its performance shows fluctuations, with year-to-date results outperforming the S&P 500."
      },
      {
        "title": "Is Universal Health Services, Inc. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-universal-health-services-inc-overvalued-or-undervalued-3612648",
        "imagepath": "",
        "date": "2025-10-12 11:07:38",
        "description": "As of 10 October 2025, the valuation grade for Universal Health Services, Inc. moved from expensive to very expensive, indicating a significant shift in its perceived value. The company is currently overvalued, with a P/E ratio of 10, a Price to Book Value of 1.80, and an EV to EBITDA ratio of 7.18. In comparison to peers, Chemed Corp. has a much higher P/E of 56.91, while National HealthCare Corp. presents a more reasonable P/E of 18.51, highlighting the disparity in valuation within the industry.\n\nRecent stock performance shows that Universal Health Services, Inc. has underperformed compared to the S&P 500 over the past year, with a return of -7.89% versus the S&P 500's 13.36%. This trend reinforces the notion that the stock may be overvalued given its lack of competitive returns in the market...."
      },
      {
        "title": "Universal Health Services, Inc. Experiences Revision in Stock Evaluation Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/universal-health-services-inc-technical-trend-upgrades-from-mildly-bullish-to-bullish-amid-stock-performance-3601221",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/UniversalHealth_technicaldot_3601221.png",
        "date": "2025-10-07 20:26:43",
        "description": "Universal Health Services, Inc. has recently seen a stock price of $206.84, reflecting a notable performance range over the past year. Technical indicators present a mixed outlook, while the stock has outperformed the S&P 500 in shorter time frames, though it has lagged in longer-term comparisons."
      }
    ],
    "total": 24,
    "sid": "1162266",
    "stock_news_url": "https://www.marketsmojo.com/news/universal-health-services-inc-1162266"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Universal Health Services, Inc. Hits New 52-Week High of $214.10

2025-10-27 16:42:49

Universal Health Services, Inc. achieved a new 52-week high of USD 214.10 on October 24, 2025, reflecting strong performance in the hospital industry. The company has shown an 11.51% increase over the past year and maintains a favorable P/E ratio, robust dividend yield, and solid financial health metrics.

Universal Health Services Faces Valuation Shift Amid Mixed Financial Performance

2025-10-23 15:40:20

Universal Health Services, Inc. has recently experienced a change in its evaluation score, reflecting a shift in its valuation grade. The company's financial metrics show a mixed performance, with strong operational capabilities and consistent positive results, despite underperforming compared to the broader market over the past year.

Is Universal Health Services, Inc. overvalued or undervalued?

2025-10-21 12:03:23

As of 17 October 2025, the valuation grade for Universal Health Services, Inc. has moved from attractive to very expensive, indicating a shift towards overvaluation. The company appears to be overvalued based on its P/E ratio of 10, which is significantly lower than the peer average, such as Chemed Corp. with a P/E of 56.91, and its EV to EBITDA ratio of 7.18, which also trails behind peers like Surgery Partners, Inc. at 8.44. Additionally, the PEG ratio stands at a notably low 0.14, suggesting that the stock may not be justified at its current price given its growth prospects. In comparison to its peers, Universal Health Services, Inc. has a lower valuation profile, with its EV to EBIT at 9.61 compared to Chemed Corp.'s 37.72 and Premier, Inc.'s 9.86. Despite a strong recent performance with a 3-year return of 116.60% compared to the S&P 500's 81.19%, the company's 1-year return of -12.64% against the S&P...

Universal Health Services, Inc. Experiences Revision in Its Stock Evaluation Amid Competitive Market Dynamics

2025-10-20 17:05:53

Universal Health Services, Inc. has adjusted its valuation, showcasing a P/E ratio of 10 and a price-to-book value of 1.80. The company features a strong dividend yield of 46.01% and competitive returns on capital and equity, positioning itself favorably against industry peers.

Is Universal Health Services, Inc. overvalued or undervalued?

2025-10-20 12:21:01

As of 17 October 2025, the valuation grade for Universal Health Services, Inc. has moved from attractive to very expensive. The company appears to be overvalued based on its current metrics. The P/E ratio stands at 10, while the industry average is not provided, indicating a potential premium valuation. Additionally, the EV to EBITDA ratio is 7.18, and the PEG ratio is notably low at 0.14, suggesting limited growth expectations relative to its price. In comparison to its peers, Universal Health Services, Inc. has a lower P/E ratio than Chemed Corp. at 56.91 and National HealthCare Corp. at 18.51, but it is higher than Surgery Partners, Inc. at 31.47. The company's recent stock performance shows a 1-week return of 4.31% and a year-to-date return of 14.01%, both outperforming the S&P 500's returns of 1.70% and 13.30%, respectively. However, the 1-year return of -12.64% significantly lags behind the S&P 500's...

Is Universal Health Services, Inc. overvalued or undervalued?

2025-10-19 11:58:32

As of 17 October 2025, the valuation grade for Universal Health Services, Inc. has moved from attractive to very expensive, indicating a shift towards overvaluation. The company is currently considered overvalued based on its P/E ratio of 10, a Price to Book Value of 1.80, and an EV to EBITDA of 7.18. In comparison, peers such as Chemed Corp. have a significantly higher P/E ratio of 56.91, while National HealthCare Corp. shows a fair valuation with a P/E of 18.51. Despite strong recent performance, with a 1-week return of 4.31% compared to the S&P 500's 1.70%, the longer-term outlook reveals a concerning 1-year return of -12.64% against the S&P 500's 14.08%. This suggests that while the stock may have short-term momentum, its overall valuation appears stretched relative to its peers and historical performance....

Universal Health Services, Inc. Experiences Valuation Adjustment Amidst Market Dynamics and Financial Metrics

2025-10-13 15:54:54

Universal Health Services, Inc. has adjusted its valuation, reflecting changes in financial metrics and market position. The company reports a P/E ratio of 10, a price-to-book value of 1.80, and a strong dividend yield of 46.01%. Its performance shows fluctuations, with year-to-date results outperforming the S&P 500.

Is Universal Health Services, Inc. overvalued or undervalued?

2025-10-12 11:07:38

As of 10 October 2025, the valuation grade for Universal Health Services, Inc. moved from expensive to very expensive, indicating a significant shift in its perceived value. The company is currently overvalued, with a P/E ratio of 10, a Price to Book Value of 1.80, and an EV to EBITDA ratio of 7.18. In comparison to peers, Chemed Corp. has a much higher P/E of 56.91, while National HealthCare Corp. presents a more reasonable P/E of 18.51, highlighting the disparity in valuation within the industry. Recent stock performance shows that Universal Health Services, Inc. has underperformed compared to the S&P 500 over the past year, with a return of -7.89% versus the S&P 500's 13.36%. This trend reinforces the notion that the stock may be overvalued given its lack of competitive returns in the market....

Universal Health Services, Inc. Experiences Revision in Stock Evaluation Amid Mixed Market Signals

2025-10-07 20:26:43

Universal Health Services, Inc. has recently seen a stock price of $206.84, reflecting a notable performance range over the past year. Technical indicators present a mixed outlook, while the stock has outperformed the S&P 500 in shorter time frames, though it has lagged in longer-term comparisons.

View All News